NCT03115047View on ClinicalTrials.gov

Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine

PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 7, 2017

Primary Completion Date

August 19, 2020

Study Completion Date

August 20, 2020

Conditions
Cesarean Section Complications
Interventions
DRUG

Dexmedetomidine Injection

0.35 mcg/kg intravenous in 2 minutes if shivering 5 minutes after delivery

DRUG

Meperidine Injection

0.35 mg/kg intravenous in 2 minutes if shivering 5 minutes after delivery

Trial Locations (1)

H2X 3J4

Centre Hospitalier de l'Université de Montréal, Montreal

All Listed Sponsors
lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03115047 - Shivering Treatment After Cesarean Delivery: Meperidine vs. Dexmedetomidine | Biotech Hunter | Biotech Hunter